- Home
- AARD vs ISTR Comparison
AARD vs ISTR Comparison
Compare AARD & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AARD | ISTR |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.9M | 256.3M |
| IPO Year | 2025 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AARD | ISTR |
|---|---|---|
| Price | $13.38 | $25.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $30.63 | $29.00 |
| AVG Volume (30 Days) | ★ 178.7K | 27.5K |
| Earning Date | 11-13-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 1.69% |
| EPS Growth | N/A | ★ 24.14 |
| EPS | N/A | ★ 2.22 |
| Revenue | N/A | ★ $93,426,000.00 |
| Revenue This Year | N/A | $7.24 |
| Revenue Next Year | N/A | $70.19 |
| P/E Ratio | ★ N/A | $11.71 |
| Revenue Growth | N/A | ★ 12.93 |
| 52 Week Low | $4.88 | $15.39 |
| 52 Week High | $19.58 | $26.33 |
Technical Indicators
Market Signals| Indicator | AARD | ISTR |
|---|---|---|
| Relative Strength Index (RSI) | 66.65 | 73.01 |
| Support Level | $9.18 | $24.62 |
| Resistance Level | $10.44 | $26.33 |
| Average True Range (ATR) | 0.91 | 0.58 |
| MACD | 0.46 | 0.18 |
| Stochastic Oscillator | 94.75 | 89.35 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.